PCC, or prothrombin complex concentrate, is a blood product given intravenously to rapidly restore the body’s ability to form clots. It’s most commonly used in emergencies to reverse the effects of the blood thinner warfarin when someone is experiencing life-threatening bleeding or needs urgent surgery. A single infusion can correct clotting ability within 10 minutes, making it one of the fastest tools available for this purpose.
If you searched “PCC” looking for poison control centers, those are 24/7 phone services that help the public and healthcare providers manage poisoning exposures. You can reach one in the U.S. by calling 1-800-222-1222. The rest of this article covers prothrombin complex concentrate.
How PCC Restores Clotting
Your blood relies on a cascade of proteins called clotting factors to stop bleeding. Warfarin works by blocking the production of four key clotting factors (labeled II, VII, IX, and X), which are all dependent on vitamin K. When someone on warfarin has a brain bleed, a serious fall, or needs emergency surgery, those missing factors need to be replaced fast.
PCC delivers concentrated versions of those same clotting factors directly into the bloodstream. The concentration is roughly 25 times higher than what’s found in normal plasma. It also contains proteins C and S, which help regulate clotting so it doesn’t go too far in the other direction. Once infused, these factors behave like the body’s own proteins, producing a rapid and sustained increase in clotting ability.
How Quickly It Works
Speed is PCC’s defining advantage. In patients studied with serial measurements, clotting markers dropped from dangerously elevated levels to near-normal range within 10 minutes of infusion. Those corrected values remained stable at 60 minutes and again at 12 to 24 hours after treatment. For context, simply stopping warfarin and giving vitamin K alone takes many hours to restore clotting, which is inadequate when someone is actively bleeding into the brain or abdomen.
The different clotting factors in PCC don’t all last the same amount of time in the body. Factor VII has the shortest half-life at roughly 4 to 5 hours, while factor II lasts the longest at about 60 hours. Factors IX and X fall in between at around 42 and 32 hours respectively. This is why PCC is typically given alongside vitamin K: the PCC handles the immediate crisis, while vitamin K helps the body resume making its own clotting factors before the shortest-lived components wear off.
3-Factor vs. 4-Factor PCC
Not all PCC products are the same. The key distinction is between 3-factor and 4-factor formulations. Both contain factors II, IX, and X, but 3-factor PCC has very little factor VII, while 4-factor PCC includes a meaningful amount of all four.
This difference matters clinically. A systematic review found that patients needing emergency warfarin reversal had more than three times the odds of reaching their target clotting levels when given 4-factor PCC compared to 3-factor. The safety profiles were similar between the two. For this reason, 4-factor PCC is generally preferred when available for urgent warfarin reversal.
PCC vs. Fresh Frozen Plasma
Before PCC became widely available, the standard approach to reversing warfarin was fresh frozen plasma (FFP), which is the liquid portion of donated blood containing all clotting factors. PCC has largely replaced FFP in emergency settings for several reasons.
A meta-analysis of randomized controlled trials in cardiac surgery patients found that PCC produced significantly better clotting correction than FFP. Patients who received PCC also lost less blood through chest drainage tubes (about 157 mL less on average) and needed nearly one fewer unit of red blood cell transfusion. This matters because FFP requires large infusion volumes, which can overload the circulatory system. That fluid overload contributes to a condition called hemodilution, where the blood becomes too diluted, sometimes creating a need for additional transfusions. FFP also carries a risk of transfusion-related acute lung injury and serious allergic reactions, complications that stem from receiving large volumes of donor plasma.
When PCC Is Used
The primary use of PCC is emergency reversal of warfarin. The most critical scenario is intracranial hemorrhage, where bleeding inside the skull can cause brain damage within minutes. Other common situations include gastrointestinal bleeding, traumatic injuries with active hemorrhage, and cases where a patient on warfarin needs emergency surgery that can’t wait for the drug to wear off naturally.
American Heart Association and American Stroke Association guidelines recommend PCC specifically for reversing warfarin-type blood thinners (called vitamin K antagonists). For newer blood thinners like apixaban and rivarexaban, which work differently, dedicated reversal agents exist. PCC is not the first-line choice for those medications, though it’s sometimes used off-label when specific reversal agents aren’t available.
Risks of PCC
The main concern with PCC is that by restoring clotting ability, you also restore the risk of unwanted clots. A systematic review and meta-analysis found that about 1.9% of patients developed a blood clot after receiving PCC, and roughly 23% of those clotting events were fatal. The risk was higher in patients treated for active bleeding (1.9%) compared to those treated before surgery (0.8%).
The type of PCC also influences risk. Four-factor PCC, while more effective at correcting clotting, carried a higher rate of clotting complications (2.3%) than 3-factor PCC (0.7%). This tradeoff between effectiveness and clotting risk is why the dose is carefully calculated based on body weight and how elevated the patient’s clotting measurements are before treatment. The inclusion of proteins C and S in the formulation helps counterbalance this risk by providing natural anticoagulant proteins alongside the clotting factors, but the risk is never zero.
PCC also contains a small amount of heparin to prevent the clotting factors from activating prematurely inside the vial, which is worth knowing for anyone with a history of heparin-related allergic reactions.